Table 1 Patients characteristics, disease status and treatment features
From: Stereotactic body radiotherapy (sbrt) in lung oligometastatic patients: role of local treatments
Characteristic | n. | % |
|---|---|---|
No. of patients | 76 | Â |
  Male | 54 | 70 |
  Female | 22 | 30 |
      68 | - |  |
Range, years | 38-88 | - |
Primary tumor | Â | Â |
  Colorectal | 29 | 38 |
  NSCLC | 18 | 24 |
  Sarcoma | 6 | 8 |
  Genitourinary | 8 | 10.5 |
  Other | 15 | 19.5 |
Other metastatic sites | Â | Â |
  Bone | 2 | 2.6 |
  Visceral | 4 | 5.2 |
Time since diagnosis (mos) | Â | Â |
  Median | 48 | - |
  Range | 10-180 | - |
Treatment | No. | % |
Lung lesions treated | 118 | Â |
No. of lung lesions (per patient) | Â | Â |
| Â | 49 | 64 |
| Â | 18 | 24 |
| Â | 9 | 12 |
Dose prescription (per lesion) | Â | Â |
  48 Gy/12 Gy fraction | 95 | 80.5 |
  60 Gy/20 Gy fraction | 7 | 6 |
  60 Gy/7.5 Gy fraction | 16 | 13.5 |